PURPOSETo assess the efficacy and safety of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) in treating recurrent small hepatocellular carcinoma (HCC).METHODSIn this trial, patients with recurrent small HCC (single lesion ≤5 cm) …
Treatment intensification strategies are reshaping the treatment landscape of metastatic castration-resistant prostate cancer. Genomic, molecular, and clinical indicators should be used to identify the optimal…
Purpose For patients with metastatic hormone-sensitive prostate cancer (mHSPC), delaying progression to castration-resistant disease is important not only for overall survival (OS) but also for…
Overcoming recurrence – how research is bringing new hope for breast cancer patients
More than a billion people live in fragile, conflict-affected, and vulnerable settings requiring humanitarian support, where cancer is a substantial health issue. Despite its substantial…
Purpose The oncology quality, characterization, and assessment of real-world data (Oncology QCARD) Initiative was formed to develop a set of minimum study design and data…
To report final results of a prospective study of stereotactic body radiotherapy (SBRT) in patients with previously untreated solitary primary hepatocellular carcinoma (HCC).
In this video, Daniel Pollyea, University of Colorado School of Medicine, Denver, CO, comments on the potential of combining omacetaxine and azacitidine for newly diagnosed…
Advocating together for equal access to optimal care for all patients with cancer in the Asia-Pacific Region
Real-world data presented at the 2024 ASH Annual Meeting evaluated the efficacy of the most common treatment sequences in CLL/SLL.
